284 related articles for article (PubMed ID: 24004562)
1. Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia.
Ronchetti D; Mosca L; Cutrona G; Tuana G; Gentile M; Fabris S; Agnelli L; Ciceri G; Matis S; Massucco C; Colombo M; Reverberi D; Recchia AG; Bossio S; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
BMC Med Genomics; 2013 Sep; 6():27. PubMed ID: 24004562
[TBL] [Abstract][Full Text] [Related]
2. The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma.
Ronchetti D; Todoerti K; Tuana G; Agnelli L; Mosca L; Lionetti M; Fabris S; Colapietro P; Miozzo M; Ferrarini M; Tassone P; Neri A
Blood Cancer J; 2012 Nov; 2(11):e96. PubMed ID: 23178508
[TBL] [Abstract][Full Text] [Related]
3. Sno/scaRNAbase: a curated database for small nucleolar RNAs and cajal body-specific RNAs.
Xie J; Zhang M; Zhou T; Hua X; Tang L; Wu W
Nucleic Acids Res; 2007 Jan; 35(Database issue):D183-7. PubMed ID: 17099227
[TBL] [Abstract][Full Text] [Related]
4. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
[TBL] [Abstract][Full Text] [Related]
5. Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.
Morabito F; Cutrona G; Mosca L; D'Anca M; Matis S; Gentile M; Vigna E; Colombo M; Recchia AG; Bossio S; De Stefano L; Maura F; Manzoni M; Ilariucci F; Consoli U; Vincelli I; Musolino C; Cortelezzi A; Molica S; Ferrarini M; Neri A
Leuk Res; 2015 Aug; 39(8):840-5. PubMed ID: 26038121
[TBL] [Abstract][Full Text] [Related]
6. Small nucleolar RNA expression profiles refine the prognostic impact of IGHV mutational status on treatment-free survival in chronic lymphocytic leukaemia.
Berquet L; Valleron W; Grgurevic S; Quelen C; Zaki O; Quillet-Mary A; Davi F; Brousset P; Bousquet M; Ysebaert L
Br J Haematol; 2016 Mar; 172(5):819-23. PubMed ID: 26095450
[No Abstract] [Full Text] [Related]
7. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.
Ronchetti D; Manzoni M; Agnelli L; Vinci C; Fabris S; Cutrona G; Matis S; Colombo M; Galletti S; Taiana E; Recchia AG; Bossio S; Gentile M; Musolino C; Di Raimondo F; Grilli A; Bicciato S; Cortelezzi A; Tassone P; Morabito F; Ferrarini M; Neri A
Blood Cancer J; 2016 Sep; 6(9):e468. PubMed ID: 27611921
[TBL] [Abstract][Full Text] [Related]
8. LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells.
Matis S; Rossi M; Brondolo L; Cardillo M; Reverberi D; Massara R; Colombo M; Ibatici A; Angelucci E; Vaisitti T; Bruno S; Fabris S; Neri A; Gentile M; Morabito F; Cutrona G; Briata P; Gherzi R; Fais F
Hematol Oncol; 2022 Feb; 40(1):40-47. PubMed ID: 34679195
[TBL] [Abstract][Full Text] [Related]
9. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
[TBL] [Abstract][Full Text] [Related]
10. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia.
Maura F; Cutrona G; Fabris S; Colombo M; Tuana G; Agnelli L; Matis S; Lionetti M; Gentile M; Recchia AG; Di Raimondo F; Musolino C; Ilariucci F; Di Renzo N; Pesce E; Molica S; Federico M; Cortelezzi A; Morabito F; Ferrarini M; Neri A
PLoS One; 2011; 6(8):e24313. PubMed ID: 21897877
[TBL] [Abstract][Full Text] [Related]
11. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
13. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
[TBL] [Abstract][Full Text] [Related]
14. Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.
Chauzeix J; Laforêt MP; Deveza M; Crowther L; Marcellaud E; Derouault P; Lia AS; Boyer F; Bargues N; Olombel G; Jaccard A; Feuillard J; Gachard N; Rizzo D
Cancer Med; 2018 Jun; 7(6):2621-2628. PubMed ID: 29745034
[TBL] [Abstract][Full Text] [Related]
15. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
[TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
Abo Elwafa R; Abd Elrahman A; Ghallab O
Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
[TBL] [Abstract][Full Text] [Related]
17. Biology and clinical relevance of noncoding sno/scaRNAs.
Cao T; Rajasingh S; Samanta S; Dawn B; Bittel DC; Rajasingh J
Trends Cardiovasc Med; 2018 Feb; 28(2):81-90. PubMed ID: 28869095
[TBL] [Abstract][Full Text] [Related]
18. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
19. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Plesingerova H; Librova Z; Plevova K; Libra A; Tichy B; Skuhrova Francova H; Vrbacky F; Smolej L; Mayer J; Bryja V; Doubek M; Pospisilova S
Leuk Lymphoma; 2017 Jan; 58(1):70-79. PubMed ID: 27185377
[TBL] [Abstract][Full Text] [Related]
20. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
